{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "17643459",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20200713",
      "reporttype": "1",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20200408",
      "receiptdateformat": "102",
      "receiptdate": "20200408",
      "fulfillexpeditecriteria": "3",
      "reportduplicate": {
        "duplicatesource": "FDA-CTU"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "2"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "23.0",
            "reactionmeddrapt": "Multiple sclerosis relapse"
          },
          {
            "reactionmeddraversionpt": "23.0",
            "reactionmeddrapt": "Stress"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TRAMADOL.",
            "activesubstance": {
              "activesubstancename": "TRAMADOL"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "DALFAMPRIDINE.",
            "drugbatchnumb": "XDAG003",
            "drugstructuredosagenumb": "10",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugadministrationroute": "048",
            "drugindication": "MULTIPLE SCLEROSIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20181120",
            "activesubstance": {
              "activesubstancename": "DALFAMPRIDINE"
            },
            "openfda": {
              "application_number": [
                "NDA022250",
                "ANDA208292",
                "ANDA206765",
                "ANDA210158",
                "ANDA206836",
                "ANDA206863",
                "ANDA206811"
              ],
              "brand_name": [
                "AMPYRA",
                "DALFAMPRIDINE"
              ],
              "generic_name": [
                "DALFAMPRIDINE"
              ],
              "manufacturer_name": [
                "Merz Pharmaceuticals, LLC",
                "Sun Pharmaceutical Industries, Inc.",
                "Ascend Laboratories, LLC",
                "Micro Labs Limited",
                "Actavis Pharma, Inc.",
                "Accord Healthcare Inc.",
                "Aurobindo Pharma Limited",
                "CivicaScript LLC"
              ],
              "product_ndc": [
                "0259-5010",
                "10144-427",
                "62756-429",
                "67877-444",
                "42571-275",
                "0591-2533",
                "16729-292",
                "65862-863",
                "82249-702"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DALFAMPRIDINE"
              ],
              "rxcui": [
                "897021",
                "897025"
              ],
              "spl_id": [
                "b0f65c2b-ee14-421f-9f24-178e108e38cf",
                "dda9045d-2f23-412c-9543-74832f421739",
                "c3c3b8ae-9dac-40fc-8569-b26d6befbf01",
                "7359109d-e6d1-4e42-bb3b-746e8d5fb686",
                "3afc3c42-1157-b612-e063-6294a90ac179",
                "f2d33c82-a69f-4f6a-bd74-2c91efd6cab8",
                "40bc3607-8ee1-5a56-e063-6294a90a3b3b",
                "8a071f78-8849-495d-ad29-832d5f250a19",
                "c40dcc84-b839-44aa-94f2-886fb1c3d75c"
              ],
              "spl_set_id": [
                "974fb2af-7012-4989-b330-e44a31c9c3e5",
                "550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783",
                "d61e15fa-0334-49a0-ab41-c9a36b726b57",
                "e10b2d92-2824-4395-8883-6fd52c784aa4",
                "302c8270-4711-4ca4-bee8-be0738fbe094",
                "ed826777-b8c4-4d35-aa64-a4c28452baa8",
                "354a97e8-35c8-418b-91b2-9e8e066cec65",
                "43996322-7d83-4420-9e61-4ed37f710fee",
                "c40dcc84-b839-44aa-94f2-886fb1c3d75c"
              ],
              "package_ndc": [
                "0259-5010-60",
                "10144-427-60",
                "62756-429-86",
                "67877-444-60",
                "67877-444-90",
                "67877-444-05",
                "42571-275-60",
                "42571-275-05",
                "42571-275-10",
                "0591-2533-60",
                "16729-292-10",
                "16729-292-12",
                "16729-292-01",
                "16729-292-16",
                "16729-292-17",
                "65862-863-60",
                "65862-863-01",
                "65862-863-05",
                "82249-702-60"
              ],
              "nui": [
                "N0000192795",
                "N0000175448"
              ],
              "pharm_class_epc": [
                "Potassium Channel Blocker [EPC]"
              ],
              "pharm_class_moa": [
                "Potassium Channel Antagonists [MoA]"
              ],
              "unii": [
                "BH3B64OKL9"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MARINOL",
            "activesubstance": {
              "activesubstancename": "DRONABINOL"
            },
            "openfda": {
              "application_number": [
                "NDA018651"
              ],
              "brand_name": [
                "MARINOL"
              ],
              "generic_name": [
                "DRONABINOL"
              ],
              "manufacturer_name": [
                "ThePharmaNetwork, LLC"
              ],
              "product_ndc": [
                "53097-568",
                "53097-569",
                "53097-570",
                "53097-571",
                "53097-572",
                "53097-573"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DRONABINOL"
              ],
              "rxcui": [
                "197634",
                "197635",
                "197636",
                "205641",
                "205642",
                "205645"
              ],
              "spl_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48"
              ],
              "spl_set_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "d0efeeec-640d-43c3-8f0a-d31324a11c68"
              ],
              "package_ndc": [
                "53097-568-60",
                "53097-569-60",
                "53097-570-60",
                "53097-571-60",
                "53097-572-60",
                "53097-573-60"
              ],
              "nui": [
                "N0000175782",
                "M0003267"
              ],
              "pharm_class_epc": [
                "Cannabinoid [EPC]"
              ],
              "pharm_class_cs": [
                "Cannabinoids [CS]"
              ],
              "unii": [
                "7J8897W37S"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "NEURONTIN",
            "activesubstance": {
              "activesubstancename": "GABAPENTIN"
            },
            "openfda": {
              "application_number": [
                "NDA020235",
                "NDA021129",
                "NDA020882"
              ],
              "brand_name": [
                "NEURONTIN"
              ],
              "generic_name": [
                "GABAPENTIN"
              ],
              "manufacturer_name": [
                "Parke-Davis Div of Pfizer Inc",
                "Viatris Specialty LLC"
              ],
              "product_ndc": [
                "0071-0805",
                "0071-0803",
                "0071-0806",
                "0071-0513",
                "0071-0401",
                "0071-2012",
                "58151-281",
                "58151-282",
                "58151-283",
                "58151-284",
                "58151-285",
                "58151-290"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "GABAPENTIN"
              ],
              "rxcui": [
                "105028",
                "105029",
                "105030",
                "261280",
                "261281",
                "283523",
                "310430",
                "310431",
                "310432",
                "310433",
                "310434",
                "351973"
              ],
              "spl_id": [
                "e730d5df-d47b-4d7f-ae3b-bd449f6b1213",
                "2d43f32d-2d96-4011-84ac-507c3307dc27"
              ],
              "spl_set_id": [
                "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388",
                "97935fd9-1d4a-43b6-a5d9-de994591187b"
              ],
              "package_ndc": [
                "0071-0803-24",
                "0071-0803-40",
                "0071-0805-24",
                "0071-0805-40",
                "0071-0806-24",
                "0071-0806-40",
                "0071-0513-24",
                "0071-0401-24",
                "0071-2012-23",
                "0071-2012-44",
                "0071-2012-47",
                "58151-281-01",
                "58151-282-01",
                "58151-283-01",
                "58151-284-01",
                "58151-285-01",
                "58151-290-35"
              ],
              "nui": [
                "N0000008486"
              ],
              "pharm_class_pe": [
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
              ],
              "unii": [
                "6CW7F3G59X"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CHOLESTYRAM POWD"
          }
        ]
      }
    }
  ]
}